Fondaparinux Sodium
Injection
To Be Discontinued Active (discontinuing) — Day 227
High impact — Sole-source drug with no supply currently available from this manufacturer.
FDA shortage record
- Substance
- Fondaparinux Sodium
- Manufacturers / suppliers
-
- Sandoz Inc.
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Dosage form
- Injection
- Presentation
- Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95)
- Route(s)
- SUBCUTANEOUS
- Therapeutic category
- Hematology
- Package NDC
0781-3476-95- Initially posted
- 09/29/2025
- Days on shortage list
- 227
- Discontinued
- 09/29/2025
- Current FDA status
- To Be Discontinued
- Shortage entries (current dataset)
- 1 record for Fondaparinux Sodium
Reason and context
Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.).
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
baa50757-a927-4d56-a933-5d7798fe6ab0). - FDA UNII identifier:
X0Q6N9USOZ. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.